191 related articles for article (PubMed ID: 21988191)
1. Collaborative study to establish a World Health Organization International genotype panel for parvovirus B19 DNA nucleic acid amplification technology (NAT)-based assays.
Baylis SA; Ma L; Padley DJ; Heath AB; Yu MW;
Vox Sang; 2012 Apr; 102(3):204-11. PubMed ID: 21988191
[TBL] [Abstract][Full Text] [Related]
2. Collaborative study to establish a replacement World Health Organization International Standard for parvovirus B19 DNA nucleic acid amplification technology (NAT)-based assays.
Baylis SA; Chudy M; Blümel J; Pisani G; Candotti D; José M; Heath AB
Vox Sang; 2010 Apr; 98(3 Pt 2):441-6. PubMed ID: 20003130
[TBL] [Abstract][Full Text] [Related]
3. World Health Organization collaborative study to calibrate the 3rd International Standard for Hepatitis C virus RNA nucleic acid amplification technology (NAT)-based assays.
Baylis SA; Heath AB;
Vox Sang; 2011 May; 100(4):409-17. PubMed ID: 21488880
[TBL] [Abstract][Full Text] [Related]
4. A proficiency testing study to evaluate laboratory performance for the detection of different genotypes of parvovirus B19.
Baylis SA; Buchheit KH
Vox Sang; 2009 Jul; 97(1):13-20. PubMed ID: 19416495
[TBL] [Abstract][Full Text] [Related]
5. Parvovirus B19 genotypes 1 and 2 detection with real-time polymerase chain reaction assays.
Koppelman MH; Rood IG; Fryer JF; Baylis SA; Cuypers HT
Vox Sang; 2007 Oct; 93(3):208-15. PubMed ID: 17845257
[TBL] [Abstract][Full Text] [Related]
6. An international collaborative study to establish the 2nd World Health Organization International Standard for hepatitis B virus DNA nucleic acid amplification technology-based assays.
Baylis SA; Heath AB; Chudy M; Pisani G; Klotz A; Kerby S; Gerlich W
Vox Sang; 2008 May; 94(4):358-62. PubMed ID: 18266781
[TBL] [Abstract][Full Text] [Related]
7. Development of the 1st International Reference Panel for HIV-1 RNA genotypes for use in nucleic acid-based techniques.
Holmes H; Davis C; Heath A
J Virol Methods; 2008 Dec; 154(1-2):86-91. PubMed ID: 18793673
[TBL] [Abstract][Full Text] [Related]
8. Standardization of nucleic acid amplification technique (NAT)-based assays for different genotypes of parvovirus B19: a meeting summary.
Baylis SA
Vox Sang; 2008 Jan; 94(1):74-80. PubMed ID: 18171331
[TBL] [Abstract][Full Text] [Related]
9. Multicenter evaluation of a commercial multiplex polymerase chain reaction test for screening plasma donations for parvovirus B19 DNA and hepatitis A virus RNA.
Koppelman MH; Cuijpers HT; Wessberg S; Valkeajärvi A; Pichl L; Schottstedt V; Saldanha J
Transfusion; 2012 Jul; 52(7):1498-508. PubMed ID: 22587637
[TBL] [Abstract][Full Text] [Related]
10. Collaborative study for establishment of a European Pharmacopoeia Biological Reference Preparation (BRP) for B19 virus DNA testing of plasma pools by nucleic acid amplification technique.
Nübling CM; Daas A; Buchheit KH
Pharmeuropa Bio; 2004 Jan; 2003(2):27-34. PubMed ID: 14960261
[TBL] [Abstract][Full Text] [Related]
11. Standardization: a progress report.
Saldanha J
Biologicals; 1999 Dec; 27(4):285-9. PubMed ID: 10686054
[TBL] [Abstract][Full Text] [Related]
12. Development of a World Health Organization International Reference Panel for different genotypes of hepatitis E virus for nucleic acid amplification testing.
Baylis SA; Hanschmann KO; Matsubayashi K; Sakata H; Roque-Afonso AM; Kaiser M; Corman VM; Kamili S; Aggarwal R; Trehanpati N; Gärtner T; Thomson EC; Davis CA; da Silva Filipe A; Abdelrahman TT; Blümel J; Terao E;
J Clin Virol; 2019 Oct; 119():60-67. PubMed ID: 31431408
[TBL] [Abstract][Full Text] [Related]
13. First WHO International Reference Panel containing hepatitis B virus genotypes A-G for assays of the viral DNA.
Chudy M; Hanschmann KM; Kress J; Nick S; Campos R; Wend U; Gerlich W; Nübling CM
J Clin Virol; 2012 Dec; 55(4):303-9. PubMed ID: 22981623
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of parvovirus B19 and human bocavirus DNA in the heart of patients with no evidence of dilated cardiomyopathy or myocarditis.
Kuethe F; Lindner J; Matschke K; Wenzel JJ; Norja P; Ploetze K; Schaal S; Kamvissi V; Bornstein SR; Schwanebeck U; Modrow S
Clin Infect Dis; 2009 Dec; 49(11):1660-6. PubMed ID: 19863443
[TBL] [Abstract][Full Text] [Related]
15. [Parvovirus B19 DNA testing in Polish blood donors, 2004-2010].
Grabarczyk P; Korzeniowska J; Liszewski G; Kalińska A; Sulkowska E; Krug-Janiak M; Kopacz A; Łetowska M; Brojer E
Przegl Epidemiol; 2012; 66(1):7-12. PubMed ID: 22708291
[TBL] [Abstract][Full Text] [Related]
16. A significantly lower potency observed for the 3rd WHO International Standard for Parvovirus B19V DNA with the cobas TaqScreen DPX test.
Pisani G; Cristiano K; Fabi S; Simeoni M; Marino F; Gaggioli A
Vox Sang; 2016 Aug; 111(2):115-9. PubMed ID: 27149002
[TBL] [Abstract][Full Text] [Related]
17. The prevalence of human parvovirus B19 DNA and antibodies in blood donors from four Chinese blood centers.
Ke L; He M; Li C; Liu Y; Gao L; Yao F; Li J; Bi X; Lv Y; Wang J; Hirsch ML; Li W
Transfusion; 2011 Sep; 51(9):1909-18. PubMed ID: 21382040
[TBL] [Abstract][Full Text] [Related]
18. A new quantitative PCR for human parvovirus B19 genotypes.
Toppinen M; Norja P; Aaltonen LM; Wessberg S; Hedman L; Söderlund-Venermo M; Hedman K
J Virol Methods; 2015 Jun; 218():40-5. PubMed ID: 25794796
[TBL] [Abstract][Full Text] [Related]
19. Identification and characterization of acute infection with parvovirus B19 genotype 2 in immunocompromised patients in Poland.
Grabarczyk P; Kalińska A; Kara M; Wieczorek R; Ejduk A; Sulkowska E; Gołębiowska-Staroszczyk S; Matysiak M; Baylis SA; Brojer E
J Med Virol; 2011 Jan; 83(1):142-9. PubMed ID: 21108352
[TBL] [Abstract][Full Text] [Related]
20. A World Health Organization International Standard for hepatitis A virus RNA nucleic acid amplification technology assays.
Saldanha J; Heath A; Lelie N; Pisani G; Yu MY;
Vox Sang; 2005 Jul; 89(1):52-8. PubMed ID: 15938741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
